Risk Stratifying Patients with RCC: Making Informed Decisions

Renal cell carcinoma experts examines risk stratification strategies to guide their treatment approaches for a 59-year-old woman with RCC.

Video Player is loading.

Play Video

Play

Mute

Current Time 0:00

/

Duration 9:13

Loaded: 0%

0:00

Stream Type LIVE

Seek to live, currently behind liveLIVE

Remaining Time -9:13

 

1x

Playback Rate

Chapters

• Chapters

Descriptions

• descriptions off, selected

Captions

• captions settings, opens captions settings dialog
• captions off, selected

Audio Track

• en (Main), selected

Fullscreen

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

Text

ColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-Transparent

Background

ColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparent

Window

ColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque

Font Size

50%75%100%125%150%175%200%300%400%

Text Edge Style

NoneRaisedDepressedUniformDropshadow

Font Family

Proportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps

Reset restore all settings to the default valuesDone

Close Modal Dialog

End of dialog window.

Close Modal Dialog

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

EP: 1.Clinical Case: Intermediate-Risk, Metastatic Clear Cell Renal Cell Carcinoma

EP: 2.Cosmic-313 and Alternate Lines of Therapy for Poor Risk Metastatic RCC

Now Viewing

EP: 3.Risk Stratifying Patients with RCC: Making Informed Decisions

EP: 4.First-Line Immune Checkpoint Inhibitors for Poor Risk Metastatic RCC

EP: 5.Treatment Recommendations for a 59-Year-Old Woman with RCC

EP: 6.Monitoring Response in Immune Checkpoint Inhibitor-Based RCC Therapy

EP: 7.Patient Case: Workup and Imaging in RCC

EP: 8.Patient Case: A 61-Year-Old Patient with Indolent Metastatic ccRCC

EP: 9.First-Line Immune Checkpoint Inhibitor for Favorable-Risk Metastatic Renal Cell Carcinoma

EP: 10.Optimizing ICI and TKI Combinations + Dose Reductions

EP: 11.Indolent Metastatic ccRCC Disease Progression and Guideline Updates

EP: 12.Third-Line Therapy for Patients with ccRCC

EP: 13.Patient Case: A 58-year-old Man With Hematuria and Abdominal Pain

EP: 14.First-Line ICI-Based Combinations for mRCC With Sarcomatoid Features

Recent Videos

First-Line ICI-Based Combinations for mRCC With Sarcomatoid Features

Patient Case: A 58-year-old Man With Hematuria and Abdominal Pain

Third-Line Therapy for Patients with ccRCC

Indolent Metastatic ccRCC Disease Progression and Guideline Updates

Optimizing ICI and TKI Combinations + Dose Reductions

First-Line Immune Checkpoint Inhibitor for Favorable-Risk Metastatic Renal Cell Carcinoma

Patient Case: A 61-Year-Old Patient with Indolent Metastatic ccRCC

Patient Case: Workup and Imaging in RCC

Monitoring Response in Immune Checkpoint Inhibitor-Based RCC Therapy

Cosmic-313 and Alternate Lines of Therapy for Poor Risk Metastatic RCC